<DOC>
	<DOCNO>NCT00206596</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness Leukine decrease need steroid treatment Crohn 's disease .</brief_summary>
	<brief_title>Study Patients With Crohn 's Disease Who Are Steroid Dependent , Despite Previous Unsuccessful Attempts Reduce Steroids Due Worsening Crohn 's Disease</brief_title>
	<detailed_description>On 29 May 2009 , Bayer begin transition sponsorship trial Genzyme . NOTE : This study originally post sponsor Berlex , Inc. Berlex , Inc. rename Bayer HealthCare , Inc .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>You must active Crohn 's disease screening diagnose Crohn 's disease within 6 month screen . You must steroid dependent disease ( receive 1040 mgs/day prednisone therapy great 3 month prior screen least one unsuccessful attempt reduce corticosteroid due worsen disease ) . You must able give injection study drug another person help give injection . You must pregnant agree use birth control sexually active male female childbearing potential . You may take medication allow study . You may GI surgery bowel obstruction last 6 month . You may ever take drug drug similar type past .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>